2877 — China Shineway Pharmaceutical Share Price
0.000.00%
Last trade - 00:00- HK$6.40bn
- -HK$148.08m
- CNY3.78bn
- 74
- 91
- 46
- 83
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 5.72 | ||
| PEG Ratio (f) | 0.63 | ||
| EPS Growth (f) | 10.05% | ||
| Dividend Yield (f) | 8.25% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.81 | ||
| Price to Tang. Book | 0.83 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.59 | ||
| EV to EBITDA | -0.12 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 15.17% | ||
| Return on Equity | 11.59% | ||
| Operating Margin | 30.49% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 2,655.7 | 3,223.55 | 3,950.64 | 4,516.54 | 3,778.04 | 3,935.3 | 4,551.95 | 6.9% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -9.9 | +21.43 | +26.86 | +34.42 | -12.72 | +8.88 | +12.36 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
China Shineway Pharmaceutical Group Ltd is an investment holding company primarily engaged in research and development, manufacturing and trading of Chinese pharmaceutical products. The Company’s product dosage forms include injections, soft capsules, granules, traditional Chinese medicine (TCM) granules, oral products and other dosage forms. The Company’s products include Qing Kai Ling Injection, Shen Mai Injection, Wu Fu Xin Nao Qing Soft Capsule, Qing Kai Ling Soft Capsule, Huamoyan Granule, Compound Licorice Tablet and other products, applied to influenza, cardio-cerebrovascular, respiratory system and other disease fields. The Company operates its business in mainland China and Hong Kong markets.
Directors
- Zhenjiang Li CHM (65)
- Tiejun Liu VPR (46)
- Yudong Zhang GMG (47)
- Bun Ching Lee CTR (48)
- Zhong Chen EDR (54)
- Huimin Li EDR (53)
- Yunxia Xin EDR (57)
- King Kuen Hung DIR (55)
- Wencheng Zhou NED (45)
- Li Cheng NID (61)
- Shun Fai Liu NID (50)
- Guoan Luo NID (74)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 14th, 2002
- Public Since
- December 2nd, 2004
- No. of Employees
- 3,232
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 827,000,000
- Address
- Luancheng, SHIJIAZHUANG
- Web
- http://www.shineway.com.hk
- Phone
- Contact
- King Kuen Hung
- Auditors
- Deloitte Touche Tohmatsu CPA
Upcoming Events for 2877
Dividend For CSWYY.PK - 0.9911 USD
China Shineway Pharmaceutical Group Ltd Annual Shareholders Meeting
China Shineway Pharmaceutical Group Ltd Annual Shareholders Meeting
Half Year 2025 China Shineway Pharmaceutical Group Ltd Earnings Release
Similar to 2877
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
AIM Vaccine Co
Stock Exchange of Hong Kong Limited
Ascletis Pharma
Stock Exchange of Hong Kong Limited
Asymchem Laboratories Tianjin Co
Stock Exchange of Hong Kong Limited
FAQ
What is the China Shineway Pharmaceutical share price?
As of Today at 23:12 UTC, shares in China Shineway Pharmaceutical are trading at HK$7.74. This share price information is delayed by 15 minutes.
How has the China Shineway Pharmaceutical share price performed this year?
Shares in China Shineway Pharmaceutical last closed at HK$7.74 and the price had moved by -17.22% over the past 365 days. In terms of relative price strength the China Shineway Pharmaceutical share price has underperformed the FTSE Developed Asia Pacific Index by -16.27% over the past year.
What are the analyst and broker recommendations for China Shineway Pharmaceutical?
The overall consensus recommendation for China Shineway Pharmaceutical is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the China Shineway Pharmaceutical dividend yield?
The China Shineway Pharmaceutical dividend yield is 7.51% based on the trailing twelve month period.
Does China Shineway Pharmaceutical pay a dividend?
Last year, China Shineway Pharmaceutical paid a total dividend of CNY0.55, and it currently has a trailing dividend yield of 7.51%.Looking ahead, shares in China Shineway Pharmaceutical are due to go ex-dividend on 2025-04-30 and the next dividend pay date is 2025-05-20.
When does China Shineway Pharmaceutical next pay dividends?
China Shineway Pharmaceutical are due to go ex-dividend on 2025-04-30 and the next dividend pay date is 2025-05-20. The historic dividend yield on China Shineway Pharmaceutical shares is currently 7.51%.
How do I buy China Shineway Pharmaceutical shares?
To buy shares in China Shineway Pharmaceutical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of China Shineway Pharmaceutical?
As of the previous close price of HK$7.74, shares in China Shineway Pharmaceutical had a market capitalisation of HK$6.40bn.
Where are China Shineway Pharmaceutical shares listed?
Here are the trading details for China Shineway Pharmaceutical:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 2877
What kind of share is China Shineway Pharmaceutical?
Based on an overall assessment of its quality, value and momentum China Shineway Pharmaceutical is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a China Shineway Pharmaceutical share price forecast for 2025?
The analyst consensus target price for shares in China Shineway Pharmaceutical is HK$12.16. That is 57.07% above the last closing price of HK$7.74.
Analysts covering China Shineway Pharmaceutical currently have a consensus Earnings Per Share (EPS) forecast of CNY1.22 for the next financial year.
Find out moreWhat is the trend in the China Shineway Pharmaceutical share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like China Shineway Pharmaceutical. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -14.12%.
As of the last closing price of HK$7.74, shares in China Shineway Pharmaceutical were trading -9.79% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the China Shineway Pharmaceutical PE Ratio?
The China Shineway Pharmaceutical PE ratio based on its reported earnings over the past 12 months is 5.72. The shares last closed at HK$7.74.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of China Shineway Pharmaceutical?
China Shineway Pharmaceutical's management team is headed by:
- Zhenjiang Li - CHM
- Tiejun Liu - VPR
- Yudong Zhang - GMG
- Bun Ching Lee - CTR
- Zhong Chen - EDR
- Huimin Li - EDR
- Yunxia Xin - EDR
- King Kuen Hung - DIR
- Wencheng Zhou - NED
- Li Cheng - NID
- Shun Fai Liu - NID
- Guoan Luo - NID